Therapeutic Targets in CLL Venetoclax in Patients With 17p Deletion Venetoclax in Patients With 17p Deletion cont Bendamustine Plus Obinutuzumab Ibrutinib Plus Ublituximab Updates in Lymphoma From Recent Congresses ID: 717369
Download Presentation The PPT/PDF document "Updates in Lymphoma From Recent Congress..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Updates in Lymphoma From Recent CongressesSlide2
Therapeutic Targets in CLLSlide3
Venetoclax in Patients With 17p DeletionSlide4
Venetoclax in Patients With 17p Deletion (cont)Slide5
Bendamustine Plus ObinutuzumabSlide6
Ibrutinib Plus UblituximabSlide7
Updates in Lymphoma From Recent CongressesSlide8
EZH2
Inhibitor TazemetostatSlide9
EZH2
Inhibitor Tazemetostat (cont)Slide10
Gene Expression Profiling in the Prediction of Disease ProgressionSlide11
Causes of Death in FLSlide12
Causes of Death in FL (cont)Slide13
FL TransformationSlide14
Cumulative Incidence by Rituximab Use
(n = 6340) Slide15
Pembrolizumab Plus RituximabSlide16
Pembrolizumab Plus Rituximab: ResultsSlide17
Lenalidomide Plus RituximabSlide18
Lenalidomide Plus Rituximab (cont)Slide19
Updates in Lymphoma From Recent CongressesSlide20
The SCHOLAR-1 StudySlide21
CAR T-Cell Therapy: CTL019Slide22
CAR T-Cell Therapy: ZUMA-1 Trial of KTE-C19 Slide23
Clinical ConclusionsSlide24
Pembrolizumab For Relapsed/Refractory Primary Mediastinal B-Cell LymphomaSlide25
Updates in Lymphoma From Recent CongressesSlide26
The BRIGHT Trial: 5-Year Follow-UpSlide27
The BRIGHT Trial: 5-Year Follow-Up (cont)Slide28
Single-Agent Lenalidomide in Relapsed or Refractory MCLSlide29
Ibrutinib vs TemsirolimusSlide30
Combining Ibrutinib With VenetoclaxSlide31
AbbreviationsSlide32
Abbreviations (cont)Slide33
Abbreviations (cont)